Generalized Anxiety Disorder: Acute and Chronic Treatment

@article{Rynn2004GeneralizedAD,
  title={Generalized Anxiety Disorder: Acute and Chronic Treatment},
  author={Moira Rynn and Olga Brawman‐Mintzer},
  journal={CNS Spectrums},
  year={2004},
  volume={9},
  pages={716 - 723}
}
Abstract Clinical and epidemiological data suggest that generalized anxiety disorder (GAD) is a chronic illness causing patients to suffer for many years leading to significant distress in daily life functioning. The literature suggests the several conclusions. GAD is a disorder in need of appropriate treatment and often has a chronic course with comorbid conditions, such as major depression and other anxiety disorders. Benzodiazepines, while effective anxiolytic agents acutely, when prescribed… Expand
Pharmacological treatment of generalized anxiety disorder
TLDR
Current pharmacological treatment options for GAD are described, with focus on benzodiazepines, azapirones, antidepressants and anticonvulsant and antipsychotic drugs. Expand
Generalized anxiety disorder: how to treat, and for how long?
  • R. Lam
  • Medicine
  • International journal of psychiatry in clinical practice
  • 2006
TLDR
Data from recent relapse-prevention studies and longer-term maintenance studies with paroxetine, venlafaxine and escitalopram strongly support the value of continued treatment for at least a further 6 months, and issues relating to the natural course of GAD are highlighted as important considerations to guide selection of pharmacotherapy. Expand
Management of treatment-resistant generalized anxiety disorder
  • E. Ansara
  • Medicine
  • The mental health clinician
  • 2020
TLDR
Evidence-based recommendations for the use of gamma-aminobutyric acid–related agents and atypical antipsychotics as adjunctive therapies for patients with treatment-resistant GAD are focused on. Expand
Atypical antipsychotics in primary generalized anxiety disorder or comorbid with mood disorders
TLDR
In a 52-week treatment of GAD, quetiapine-XR was superior to placebo in the prevention of anxiety relapses and atypical antipsychotics were relatively well tolerated, with common side effects of somnolence and sedation. Expand
Pediatric Generalized Anxiety Disorder
TLDR
It is recommended to continue medication for approximately 1 year following remission in symptoms, and when discontinuing medication to choose a stress-free time of the year, and if symptoms return, medication re-initiation should be considered seriously. Expand
Pharmacotherapy of generalized anxiety disorder: focus and update on pregabalin
TLDR
Evidence from available randomized placebo-controlled as well as head-to-head clinical trials with other drugs regarding its efficacy and safety in the GAD treatment is evaluated. Expand
Duration of Untreated Illness as a Predictor of Treatment Response and Clinical Course in Generalized Anxiety Disorder
TLDR
Results from this preliminary study seem to suggest that a shorter DUI-AD may determine a better response to pharmacologic treatment in patients with GAD, and that a longer DUI (DUI-BDZ and DUI- AD) may be associated to a worse clinical course. Expand
Occupational functioning, sickness absence and medication utilization before and after cognitive-behaviour therapy for generalized anxiety disorders.
TLDR
The data suggest that CBT is not only efficacious in terms of symptom reduction but also efficient in Terms of reducing inappropriate medication intake and improving occupational functioning. Expand
Escitalopram for older adults with generalized anxiety disorder: a randomized controlled trial.
TLDR
Older adults with GAD randomized to escitalopram had a higher cumulative response rate for improvement vs placebo over 12 weeks; however, response rates were not significantly different using an intention-to-treat analysis. Expand
Pharmacotherapy of anxiety disorders: a critical review
TLDR
A considerable database of studies shows efficacy and relative tolerability of the selective serotonin reuptake inhibitors in the major anxiety disorders, and secondary analyses of such datasets have informed questions such as optimal definition of response and remission, optimal dose and duration, and comparative efficacy of different agents. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 94 REFERENCES
Optimizing pharmacotherapy of generalized anxiety disorder to achieve remission.
  • M. Pollack
  • Medicine
  • The Journal of clinical psychiatry
  • 2001
TLDR
To optimize treatment for GAD with the goal of achieving remission, it is reasonable to select an agent with demonstrated effectiveness for Gad and associated comorbidities as well as a favorable side effect profile. Expand
Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam.
TLDR
The results of the study need replication, but suggest a potentially important role for antidepressants, particularly imipramine, in patients suffering from GAD. Expand
Treatment of generalised anxiety disorder with a short course of psychological therapy, combined with buspirone or placebo.
TLDR
A short course of psychological therapy, whether or not accompanied by active medication, was an effective treatment for patients diagnosed as having quite severe symptoms of GAD. Expand
Generalized anxiety disorder.
Generalized anxiety disorder is a relatively new clinical entity and current understanding of this syndrome lacks a solid research base. However, useful generalizations can be derived from earlierExpand
Interaction of pharmacological and psychological treatments of anxiety.
  • M. Lader, A. Bond
  • Psychology, Medicine
  • The British journal of psychiatry. Supplement
  • 1998
TLDR
There is some evidence that short-term, combined treatment does confer additional benefits which are evident both in speed of onset and lasting remission of generalised anxiety disorder. Expand
Efficacy and tolerability of paroxetine for the long-term treatment of generalized anxiety disorder.
BACKGROUND Paroxetine has demonstrated efficacy in depression and anxiety disorders, including generalized anxiety disorder (GAD). This 32-week study evaluated the maintained efficacy and safety ofExpand
Clinical guidelines for establishing remission in patients with depression and anxiety.
  • J. Ballenger
  • Medicine, Psychology
  • The Journal of clinical psychiatry
  • 1999
TLDR
Treatment guidelines for patients with anxiety disorders more closely approximate the types of patients seen in clinical practice and propose full remission and functional recovery as the goal of treatment. Expand
Maintenance therapy of persons with schizophrenia.
  • W. Carpenter
  • Psychology, Medicine
  • The Journal of clinical psychiatry
  • 1996
TLDR
Optimal maintenance treatment incorporates early detection and outpatient management of symptom exacerbation, minimal dosing to increase compliance and reduce adverse effects, psychosocial intervention to reduce relapse rates and enhance functioning, and the integration of several therapeutic modalities and the provision of case managers and assertive community treatment teams. Expand
Factors predicting the clinical course of generalised anxiety disorder
TLDR
Full or partial remissions were less likely to occur in patients with poor relationships and personality disorders, and these patients should be given more intensive and possibly multi-modal therapy. Expand
Phenomenology and course of generalised anxiety disorder.
TLDR
The chronicity associated with GAD is confirmed and this finding is extended to define the one and two year remission rates for the disorder. Expand
...
1
2
3
4
5
...